MemoVance Pro Official Website › Cognitive supplement guide
Cognitive supplement guideCognitive Supplement Guide: What The Evidence Shows
Across this shelf the honest summary is narrow, and it is mostly about dose.
The nitric oxide amino acids have a real vascular literature that begins at four grams a day. Beta-alanine has mixed cognitive results at 2.4 grams. Carnosine itself has the strongest recall finding. Almost every supplement on the shelf carries a fraction of any of those figures.
Family by family, what was measured, in whom, at what dose, and what it means.
What this guide covers, and what it leaves alone
Four families in, five out, and the reason for the line.
Four ingredient families are covered here, and they are the four that turn up on amino-acid cognitive formulas: arginine and its alpha-ketoglutarate salt, citrulline in its two common salts, beta-alanine and the carnosine it builds, and the B3 and NAD route.
Five families are deliberately left alone: bacopa, ginkgo, lion’s mane, citicoline and phosphatidylserine. Each has a literature and none of it was verified against a live source in the session that assembled this site’s references. Writing about their evidence would mean citing from memory, and a citation written from memory is the one failure mode this desk refuses outright.
So this guide is narrower than a complete survey of the category and it is checkable line by line, which is the trade worth making. A reader comparing a botanical formula should look for a guide whose author verified those sources.
One organising idea runs through all four sections. In this category the interesting question is almost never whether an ingredient does anything. It is whether the amount on the label is anywhere near the amount that did it.
The nitric oxide amino acids: a vascular literature, not a memory one
Four ingredients, one pathway, and the doses that engaged it.
L-arginine is the direct substrate for nitric oxide synthase. Nitric oxide relaxes the smooth muscle around a blood vessel, and a relaxed vessel carries more blood at lower pressure. That is the mechanism the whole family rests on and it is not in dispute.
The dose at which swallowing arginine does that is the useful number. A 2022 dose-response meta-analysis in Advances in Nutrition pooled the randomised trials and found blood pressure moved at four grams a day and above, with nothing detectable below it and nothing further above about nine grams. A 2026 reassessment using ambulatory blood pressure monitoring revisited the question with better measurement.
Citrulline reaches the same chemistry by a better route. Swallowed arginine is largely stripped out by arginase before it reaches the circulation; citrulline passes that checkpoint and is converted to arginine in the kidney. Schwedhelm's 2008 pharmacokinetic study tested a ladder of doses and found that only the top rung, three grams twice a day, lifted the plasma arginine trough.
The alpha-ketoglutarate salt has a thinner and older file. The eight-week pharmacokinetic and safety study in trained men used twelve grams a day and the seven-day blood-flow trial used the same, while three grams taken acutely and 3,700 mg per serving both failed to move anything.
Citrulline malate is the performance form. The meta-analysis of repetitions during strength training covers six to eight grams taken forty to sixty minutes beforehand, and the review of perceived exertion and soreness reports eight grams as the commonest dose. Against all of that, eight days of eight grams a day of either amino acid did not improve a swimmer’s time trial.
Two further findings are worth having. A gram and a half of citrulline a day for a month improved erection hardness in men with mild erectile dysfunction, and 800 mg paired with trans-resveratrol is the lowest citrulline dose with a positive human result in this search. Both describe vascular endpoints, which is what this family is.
The one study that reaches cognition is an acute trial of inositol-stabilised arginine silicate, which reported improved cognitive outcomes in healthy adults at 1.5 g of a stabilised compound. It is a real result, it is one study, and the compound is not the free base that appears on most labels.
Beta-alanine and carnosine: the family with the recall finding
A slow-building precursor, mixed cognitive results, and a better result for the dipeptide itself.
Beta-alanine has nothing to do with nitric oxide. It is the rate-limiting precursor for carnosine, a dipeptide stored in muscle and, in smaller quantities, in brain tissue, where it acts as a buffer and an antioxidant.
The International Society of Sports Nutrition position stand sets the working dose at four to six grams a day for at least four weeks, and notes that the tingling most people associate with the ingredient is managed by splitting intake into 1.6 g portions. A comparison of two loading protocols found twelve grams a day of a sustained-release form accelerated carnosine loading, and a Bayesian dose-response analysis modelled the relationship across the literature.
The cognitive results are genuinely mixed and both directions deserve printing. A double-blind randomised study in older adults at 2.4 g a day reported changes in cognitive function, mood and physical function; an imaging follow-up found altered fractional anisotropy in the hippocampus and amygdala at the same dose; and an executive-function trial in middle-aged adults used 2.4 g for twenty-eight days.
Against those, a trial in combat soldiers found tactical performance improved while cognitive function did not, with a follow-up confirming muscle carnosine had risen. Twelve grams a day for a fortnight was tested before simulated operational stress, and fourteen weeks alongside interval training moved neither serum BDNF nor Stroop performance.
The strongest thread in this whole guide runs through carnosine itself rather than its precursor. A 2024 meta-analysis of histidine-containing dipeptides found improved delayed recall, and the NEAT trial gave two grams of carnosine daily for up to twelve weeks with improvements in the younger participants.
That distinction is the practical lesson of this family. Supplying carnosine directly and supplying the precursor that builds it over weeks are different propositions with different evidence, and a label carrying beta-alanine is doing the second.
The B3 and NAD route: a real pathway at doses nobody puts in a capsule
A genuine pathway, studied with a different compound, in grams.
Niacin is converted into nicotinamide adenine dinucleotide, the coenzyme that carries electrons through cellular energy production. Neurons are metabolically expensive and their demand for it is continuous, which is the honest reason B3 appears on cognitive labels.
The cognition research in this area does not use niacin. It uses nicotinamide riboside, a different compound, at doses between one and two grams a day. A randomised placebo-controlled trial in older adults with mild cognitive impairment escalated to a gram a day for ten weeks. A 2025 trial in subjective cognitive decline used the same gram a day for eight weeks. A long-COVID trial used two grams.
Niacin’s own large literature is cardiovascular and also runs in grams. HPS2-THRIVE gave 25,673 adults two grams a day of an extended-release form, and an FDA Mini-Sentinel assessment examined prescription-strength niacin in routine use.
At food-level amounts none of that applies and neither does the flush. The 2024 review of the flushing mechanism describes a prostaglandin-mediated response to doses in the hundreds of milligrams, so a capsule carrying single-figure milligrams produces nothing a person will notice.
The reasonable reading is that a niacin row on a cognitive label is a nutritional contribution rather than an active intervention. That is a modest thing and a real one, and it is the row most likely on any such label to be at an amount the reference figures actually support.
The mineral rows: usually a timing question rather than an active
What a small mineral row is actually for on a label like this.
Small mineral rows turn up constantly on this shelf and are almost never doing nutritional work. Their practical significance is whether they interfere with something else you take.
Calcium is the one that matters, because calcium carbonate binds levothyroxine in the gut. The threshold is what a reader needs and it is available: the work that first established the interaction ran at 1,200 mg of the element daily, and a later comparison across three calcium salts halved that to 500 mg and still found it.
That gives a reader a usable threshold rather than a vague caution. A label carrying tens of milligrams of calcium is far below anything that has been tested for interference; a label carrying hundreds is in the territory the studies covered and is worth separating from a thyroid dose.
The general lesson applies beyond calcium. When a mineral row appears at a fraction of a Daily Value, the right question is not what it contributes but whether it collides with anything, and the answer is usually available from the dose in the interaction literature rather than from the label.
Dose is the whole question in this category
Seven ingredients, the trial dose and the shelf dose side by side.
| Ingredient | Dose in the published work | What a typical capsule carries |
|---|---|---|
| L-arginine | 4 g a day and above before blood pressure moved | Tens to low hundreds of milligrams |
| L-arginine AKG | 12 g a day in both trials that examined it | Low hundreds of milligrams |
| L-citrulline | 3 g twice a day to lift the plasma arginine trough | Tens to low hundreds of milligrams |
| Citrulline malate | 6 to 8 g before exercise | Tens to low hundreds of milligrams |
| Beta-alanine | 4 to 6 g a day for four weeks or more | Tens of milligrams |
| Carnosine, given directly | 2 g a day for up to twelve weeks | Rarely present at all |
| Nicotinamide riboside | 1 to 2 g a day in the cognition trials | Not the same compound as the niacin on most labels |
The middle column is what the trials used. The right-hand column is what this category generally sells, across brands.
Set out like that, the position across the shelf is uncomfortable and it is not specific to any one brand. The gap between the trial dose and the capsule dose in this category regularly runs between twentyfold and a hundredfold.
Two honest responses exist to that and they are different. The first is that a supplement is not a trial: it is a small daily contribution taken over months rather than a therapeutic dose taken for eight weeks, and nobody claims otherwise. The second is that a twentyfold gap is not a smaller version of an effect, it is usually no version of it, because the pooled analyses found nothing below their thresholds rather than a little something.
Which of those a reader finds persuasive is properly their decision. What a guide can do is make sure the decision is made with both numbers visible, which is why the middle column of that table appears on every ingredient page on this website too.
How to read a cognitive supplement label in two minutes
Six steps, in the order that saves the most time.
- Find the serving size first. Every other figure on the panel is per serving, and a three-capsule serving makes a panel look three times stronger than a one-capsule one.
- Look for a proprietary blend. A blend total with no individual amounts means nothing below it can be compared with anything, and the rest of this exercise stops there.
- Read the form, not just the name. Arginine base and arginine AKG are different rows with different literatures, and an extract weight is not an active weight.
- Add the actives. One number, in milligrams, for the whole serving. It is usually smaller than the front of the pack implies.
- Compare it with the middle column above. One ingredient at a trial dose is worth more than eight at a gesture.
- Read the other-ingredients line. The capsule shell decides whether the product suits a vegetarian diet, and it is the line most often skipped.
Six steps, none of which needs any specialist knowledge, and between them they sort most of this shelf. The one that does the most work is the fourth, because a total expressed in milligrams can be held against a figure expressed in grams without any further thought.
The companion checklist turns the same idea into seven scored questions and applies them to a real label.
What a supplement in this category is allowed to claim
The permitted vocabulary, and why it makes two packs sound identical.
Dietary supplements in the United States may make structure and function claims. They may say a product supports cognitive function; they may not say it treats, prevents or cures anything, including any form of cognitive decline.
That boundary is why the phrases on this shelf repeat. Cognitive function, mental clarity, focus and healthy brain function are the vocabulary available, and a product claiming more than that has stepped outside what its category permits.
Every such claim carries the same disclaimer. These statements have not been evaluated by the Food and Drug Administration, and the product is not intended to diagnose, treat, cure or prevent any disease. No supplement in this category is FDA-approved, because none of them is a drug.
The practical consequence for a reader is that the claims on the front of two packs carry almost no information, since both are drawn from the same narrow permitted vocabulary. The panel on the back carries all of it.
The short version of all of this
Six statements, and the one that does the most work.
- The nitric oxide amino acids have a real literature and it is vascular. The arginine threshold in the pooled data is four grams a day.
- Citrulline is the better entry point into that chemistry, and the dose that moved plasma arginine was three grams twice a day.
- Beta-alanine builds carnosine over four weeks at four to six grams a day. Its cognitive results at 2.4 grams point both ways.
- The best recall finding in this whole guide is for carnosine supplied directly, not for the precursor.
- The B3 cognition trials used nicotinamide riboside at one to two grams, which is a different compound at a thousand times a food-level niacin row.
- In every family, the gap between the trial dose and the shelf dose is the fact that decides what a capsule is worth.
A reader who takes only one thing from this guide should take the last line. Ingredient lists in this category are easy to admire and almost never the thing that matters.
The checklist applies that to a real label, and the ingredients page on this site prints the trial dose beside every amount on the product this website sells.
Sources for this guide
Every study named above, grouped by the family it belongs to.
- Shiraseb F, Asbaghi O, Bagheri R, et al. Effect of l-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials. Adv Nutr. 2022;13(4):1226-1242. PMID 34967840. https://pubmed.ncbi.nlm.nih.gov/34967840/
- Shi Y, Liu Y, Zhou Z, et al. Reassessment of the effect of oral l-arginine on blood pressure: A systematic review and meta-analysis based on ambulatory blood pressure monitoring. Nitric Oxide. 2026;164:60-68. PMID 42520885. https://pubmed.ncbi.nlm.nih.gov/42520885/
- Greer BK, Jones BT. Acute arginine supplementation fails to improve muscle endurance or affect blood pressure responses to resistance training. J Strength Cond Res. 2011;25(7):1789-94. PMID 21399536. https://pubmed.ncbi.nlm.nih.gov/21399536/
- Gills JL, Campitelli A, Jones M, et al. Acute Inositol-Stabilized Arginine Silicate Improves Cognitive Outcomes in Healthy Adults. Nutrients. 2021;13(12):4272. PMID 34959823. https://pubmed.ncbi.nlm.nih.gov/34959823/
- Campbell B, Roberts M, Kerksick C, et al. Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men. Nutrition. 2006;22(9):872-81. PMID 16928472. https://pubmed.ncbi.nlm.nih.gov/16928472/
- Willoughby DS, Boucher T, Reid J, et al. Effects of 7 days of arginine-alpha-ketoglutarate supplementation on blood flow, plasma L-arginine, nitric oxide metabolites, and asymmetric dimethyl arginine after resistance exercise. Int J Sport Nutr Exerc Metab. 2011;21(4):291-9. PMID 21813912. https://pubmed.ncbi.nlm.nih.gov/21813912/
- Wax B, Kavazis AN, Webb HE, et al. Acute L-arginine alpha ketoglutarate supplementation fails to improve muscular performance in resistance trained and untrained men. J Int Soc Sports Nutr. 2012;9(1):17. PMID 22510253. https://pubmed.ncbi.nlm.nih.gov/22510253/
- Schwedhelm E, Maas R, Freese R, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol. 2008;65(1):51-9. PMID 17662090. https://pubmed.ncbi.nlm.nih.gov/17662090/
- Cormio L, De Siati M, Lorusso F, et al. Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology. 2011;77(1):119-22. PMID 21195829. https://pubmed.ncbi.nlm.nih.gov/21195829/
- Shirai M, Hiramatsu I, Aoki Y, et al. Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study. Sex Med. 2018;6(4):291-296. PMID 30150102. https://pubmed.ncbi.nlm.nih.gov/30150102/
- Esen O, Eser MC, Abdioglu M, et al. Eight Days of L-Citrulline or L-Arginine Supplementation Did Not Improve 200-m and 100-m Swimming Time Trials. Int J Environ Res Public Health. 2022;19(8):4462. PMID 35457330. https://pubmed.ncbi.nlm.nih.gov/35457330/
- Varvik FT, Bjornsen T, Gonzalez AM. Acute Effect of Citrulline Malate on Repetition Performance During Strength Training: A Systematic Review and Meta-Analysis. Int J Sport Nutr Exerc Metab. 2021;31(4):350-358. PMID 34010809. https://pubmed.ncbi.nlm.nih.gov/34010809/
- Rhim HC, Kim SJ, Park J, et al. Effect of citrulline on post-exercise rating of perceived exertion, muscle soreness, and blood lactate levels: A systematic review and meta-analysis. J Sport Health Sci. 2020;9(6):553-561. PMID 33308806. https://pubmed.ncbi.nlm.nih.gov/33308806/
- Trexler ET, Smith-Ryan AE, Stout JR, et al. International society of sports nutrition position stand: Beta-Alanine. J Int Soc Sports Nutr. 2015;12:30. PMID 26175657. https://pubmed.ncbi.nlm.nih.gov/26175657/
- Rezende NS, Swinton P, de Oliveira LF, et al. The Muscle Carnosine Response to Beta-Alanine Supplementation: A Systematic Review With Bayesian Individual and Aggregate Data E-Max Model and Meta-Analysis. Front Physiol. 2020;11:913. PMID 32922303. https://pubmed.ncbi.nlm.nih.gov/32922303/
- Church DD, Hoffman JR, Varanoske AN, et al. Comparison of Two beta-Alanine Dosing Protocols on Muscle Carnosine Elevations. J Am Coll Nutr. 2017;36(8):608-616. PMID 28910200. https://pubmed.ncbi.nlm.nih.gov/28910200/
- Ostfeld I, Ben-Zeev T, Zamir A, et al. Role of beta-Alanine Supplementation on Cognitive Function, Mood, and Physical Function in Older Adults; Double-Blind Randomized Controlled Study. Nutrients. 2023;15(4):923. PMID 36839281. https://pubmed.ncbi.nlm.nih.gov/36839281/
- Ostfeld I, Zamir A, Ben-Zeev T, et al. beta-Alanine supplementation improves fractional anisotropy scores in the hippocampus and amygdala in 60-80-year-old men and women. Exp Gerontol. 2024;194:112513. PMID 38971131. https://pubmed.ncbi.nlm.nih.gov/38971131/
- Furst T, Massaro A, Miller C, et al. beta-Alanine supplementation increased physical performance and improved executive function following endurance exercise in middle aged individuals. J Int Soc Sports Nutr. 2018;15(1):32. PMID 29996843. https://pubmed.ncbi.nlm.nih.gov/29996843/
- Varanoske AN, Wells AJ, Boffey D, et al. Effects of High-Dose, Short-Duration beta-Alanine Supplementation on Cognitive Function, Mood, and Circulating Brain-Derived Neurotropic Factor (BDNF) in Recreationally-Active Males Before Simulated Military Operational Stress. J Diet Suppl. 2021;18(2):147-168. PMID 32138563. https://pubmed.ncbi.nlm.nih.gov/32138563/
- Hoffman JR, Landau G, Stout JR, et al. beta-alanine supplementation improves tactical performance but not cognitive function in combat soldiers. J Int Soc Sports Nutr. 2014;11(1):15. PMID 24716994. https://pubmed.ncbi.nlm.nih.gov/24716994/
- Hoffman JR, Landau G, Stout JR, et al. beta-Alanine ingestion increases muscle carnosine content and combat specific performance in soldiers. Amino Acids. 2015;47(3):627-36. PMID 25510839. https://pubmed.ncbi.nlm.nih.gov/25510839/
- Mendonca PT, Dutra YM, Antunes BM, et al. Fourteen weeks of beta-alanine supplementation and HIIT did not improve serum BDNF concentrations and Stroop test performance. Int J Sports Med. 2025;46(5):324-333. PMID 39832765. https://pubmed.ncbi.nlm.nih.gov/39832765/
- Bell SM, Hariharan R, Laud PJ, et al. Histidine-containing dipeptide supplementation improves delayed recall: a systematic review and meta-analysis. Nutr Rev. 2024;82(10):1372-1385. PMID 38013229. https://pubmed.ncbi.nlm.nih.gov/38013229/
- O'Toole TE, Amraotkar AR, Gao H, et al. Carnosine supplementation improves cognitive outcomes in younger participants of the NEAT trial. Neurotherapeutics. 2025;22(2):e00541. PMID 39919936. https://pubmed.ncbi.nlm.nih.gov/39919936/
- Landray MJ, Haynes R, Hopewell JC, et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014;371(3):203-12. PMID 25014686. https://pubmed.ncbi.nlm.nih.gov/25014686/
- Javaid A, Mudavath SL. Niacin-induced flushing: Mechanism, pathophysiology, and future perspectives. Arch Biochem Biophys. 2024;761:110163. PMID 39322100. https://pubmed.ncbi.nlm.nih.gov/39322100/
- Gagne JJ, Houstoun M, Reichman ME, et al. Safety assessment of niacin in the US Food and Drug Administration's mini-sentinel system. Pharmacoepidemiol Drug Saf. 2018;27(1):30-37. PMID 29108128. https://pubmed.ncbi.nlm.nih.gov/29108128/
- Orr ME, Kotkowski E, Ramirez P, et al. A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. Geroscience. 2024;46(1):665-682. PMID 37994989. https://pubmed.ncbi.nlm.nih.gov/37994989/
- Wu CY, Kupferschmid AC, Chen L, et al. Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment. Alzheimers Dement (N Y). 2025;11(1):e70023. PMID 39817194. https://pubmed.ncbi.nlm.nih.gov/39817194/
- Wu CY, Reynolds WC, Abril I, et al. Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. EClinicalMedicine. 2025;89:103633. PMID 41357333. https://pubmed.ncbi.nlm.nih.gov/41357333/
- Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000;283(21):2822-5. PMID 10838651. https://pubmed.ncbi.nlm.nih.gov/10838651/
- Zamfirescu I, Carlson HE. Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid. 2011;21(5):483-6. PMID 21595516. https://pubmed.ncbi.nlm.nih.gov/21595516/
See how MemoVance Pro scores against all of this
Seven printed amounts, each one set beside the dose its own research used, and 180 days from purchase to change your mind.
Two bottles $158 · six bottles $294 · 180-day money-back guarantee
Order MemoVance Pro On The Official WebsiteLot MEM-26/ME-2602 · 30 capsules · one swallowed each day